3 years ago

Identification and Optimization of Pyrrolo[3,2-d]pyrimidine Toll-like Receptor 7 (TLR7) Selective Agonists for the Treatment of Hepatitis B

Identification and Optimization of Pyrrolo[3,2-d]pyrimidine Toll-like Receptor 7 (TLR7) Selective Agonists for the Treatment of Hepatitis B
Helen Horton, Florence Herschke, Pierre Raboisson, Jin Hong, Dorien Verstappen, Ilham Smyej, Tim H. M. Jonckers, Bertrand Van Schoubroeck, Debbie Wuyts, Eric Arnoult, Mourad Daoubi Khamlichi, Marianne Tuefferd, Jacques Bollekens, Deborah Dhuyvetter, Wendy Mostmans, Tine Thoné, Herman Borghys, Bart Stoops, Gregory Fanning, Dorien De Pooter, Serge Pieters, Ard Teisman, Frederik Pauwels, Vijay Urmaliya, Werner Embrechts, David C. McGowan, Stefaan Last, Annick Scholliers
Pyrrolo[3,2-d]pyrimidines were identified as a new series of potent and selective TLR7 agonists. Compounds were optimized for their activity and selectivity over TLR8. This presents an advantage over recently described scaffolds that have residual TLR8 activity, which may be detrimental to the tolerability of the candidate drug. Oral administration of the lead compound 54 effectively induced a transient interferon stimulated gene (ISG) response in mice and cynomolgus monkeys. We aimed for a high first pass effect, limiting cytokine induction systemically, and demonstrated the potential for the immunotherapy of viral hepatitis.

Publisher URL: http://dx.doi.org/10.1021/acs.jmedchem.7b00365

DOI: 10.1021/acs.jmedchem.7b00365

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.